B
B. Lafferty wrote:
> Quoting Coyle, "To our knowledge, there have been no longitudinal studies
> performed over years on humans directly testing the hypothesis that type II
> fibers can be converted to type I muscle fibers with continued intense
> endurance training."
>
> And Coyle noted other factors that could contribute to increased efficiency,
> "Other factors that have been reported to increase cycling efficiency and
> running economy are intermittent exposure to hypoxia for several weeks as
> encountered by athletes who spend periods living at high altitude or in
> hypoxic environments. Like many endurance athletes, this individual has
> incorporated hypoxic exposure into his annual plan, which may be another
> factor contributing to improved cycling efficiency."
> Dare we point out that EPO, as found in Armstrong's urine in the 1999 Tour,
> increases efficiency without the need for hypoxic exposure?
Laff, you and Coggan have been over this before, and you
haven't learned what efficiency means.
<http://groups.google.com/group/rec.bicycles.racing/browse_frm/thread/5e9418f3e9dccd08/e6dd219fcfec1459#e6dd219fcfec1459>
Efficiency is power divided by oxygen uptake. (In Coyle's study
of Armstrong, both of these numbers were measured.) EPO works
by increasing the amount of oxygen the cardio system can deliver.
It increases the supply of fuel to the engine, not the efficiency with
which the engine turns the fuel into usable power. As Coggan said,
EPO use would increase the amount of oxygen respired
(VO2max or VO2 at LT).
If you have a citation which shows that EPO or other doping agents
can increase efficiency - not total power, but efficiency as defined
above - I'd be happy to read it.
IMO, Coyle's paper doesn't prove anything about Armstrong's use
or lack of doping; but your reading of it does prove something.
Ben
> Quoting Coyle, "To our knowledge, there have been no longitudinal studies
> performed over years on humans directly testing the hypothesis that type II
> fibers can be converted to type I muscle fibers with continued intense
> endurance training."
>
> And Coyle noted other factors that could contribute to increased efficiency,
> "Other factors that have been reported to increase cycling efficiency and
> running economy are intermittent exposure to hypoxia for several weeks as
> encountered by athletes who spend periods living at high altitude or in
> hypoxic environments. Like many endurance athletes, this individual has
> incorporated hypoxic exposure into his annual plan, which may be another
> factor contributing to improved cycling efficiency."
> Dare we point out that EPO, as found in Armstrong's urine in the 1999 Tour,
> increases efficiency without the need for hypoxic exposure?
Laff, you and Coggan have been over this before, and you
haven't learned what efficiency means.
<http://groups.google.com/group/rec.bicycles.racing/browse_frm/thread/5e9418f3e9dccd08/e6dd219fcfec1459#e6dd219fcfec1459>
Efficiency is power divided by oxygen uptake. (In Coyle's study
of Armstrong, both of these numbers were measured.) EPO works
by increasing the amount of oxygen the cardio system can deliver.
It increases the supply of fuel to the engine, not the efficiency with
which the engine turns the fuel into usable power. As Coggan said,
EPO use would increase the amount of oxygen respired
(VO2max or VO2 at LT).
If you have a citation which shows that EPO or other doping agents
can increase efficiency - not total power, but efficiency as defined
above - I'd be happy to read it.
IMO, Coyle's paper doesn't prove anything about Armstrong's use
or lack of doping; but your reading of it does prove something.
Ben